PMCPA Case Library

1,752 PMCPA Rulings.
Every One Analysed.

The only structured, searchable PMCPA case library in the UK. Expert video walkthroughs, podcast episodes, and MCQ assessments on every ruling — so you understand why companies breach the Code, not just that they did.

▶ Video analysis per case
🎧 Podcast per case
✍ MCQ + CPD certificate
🔒 From £299/year
1752+
Case Studies
5 min
Per Video
5 pts
Per Case Passed
8
Themes
📚
Subscribe for full case library access
Read free summaries below, or subscribe to unlock expert video walkthroughs, podcast audio and CPD certificates.
Free — Browsing
✓ Browse all 1752+ case titles
✓ Filter by theme & therapy area
✓ See case reference, company & outcome
Search by company or clause
Video walkthroughs
Podcast episodes
MCQ assessments & CPD certificates
Subscribed — Full Access
✓ Search by company, clause & case ref
✓ Expert video walkthrough per case
✓ Podcast episode per case
✓ MCQ quiz — 5 CPD points per pass
✓ Personalised CPD completion certificate
✓ New cases added monthly
Subscribe from £299/year →
Search by company, clause, case reference... 🔒
Therapy Area: All areas Other (360) Oncology (218) Cardiovascular (189) Respiratory (178) CNS & Neurology (169) Infectious Diseases (115) Diabetes (114) Rare Diseases (104) Immunology & Rheumatology (84) Dermatology (67) Obesity & Weight Management (63) Musculoskeletal & Bone (60) Ophthalmology (31)
🔒 Subscribers only
AUTH/2972/8/17
Social Media & Digital Not Upheld 🏥 Other ▶ Video 🎙 Podcast
UCB website governance failures
An anonymous, non-contactable complainant (stating they were a healthcare journalist) complained about content on the UCB Pharma Ltd UK website and provided annotated screenshots.The website sectio…
Clauses: NONE
🔒 Subscribers only
AUTH/2968/8/17
Data & Publications Not Upheld 🏥 Ophthalmology ▶ Video 🎙 Podcast
Bausch & Lomb
A letter in The Pharmaceutical Journal (July 2017) criticised Bausch & Lomb’s claims that Emerade (adrenaline auto-injector) had a 30-month shelf-life versus 18 months for EpiPen.The complain…
Clauses: NONE
🔒 Subscribers only
AUTH/2951/4/17
Social Media & Digital Not Upheld 🏥 Diabetes ▶ Video 🎙 Podcast
Sanofi breached ABPI Code over Toujeo “Latest Data” app implying hypoglycaemia benefit from clamp-st
A consultant physician complained about Sanofi’s promotion of Toujeo (insulin glargine 300U/ml) using a digital “Latest Data” iPad app (ref SAGB.TJO.16.12.1140(1)a, March 2017).The app presen…
Clauses: NONE
🔒 Subscribers only
AUTH/3005/12/17
Social Media & Digital Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Biogen
A 2017 transparency study (published in Current Medical Research & Opinion) assessed whether results of company-sponsored trials linked to EMA-approved 2014 medicines were disclosed within set …
Clauses: NONE
🔒 Subscribers only
AUTH/2993/11/17
HCP Hospitality & Meetings Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
Napp
A complaint alleged a conflict of interest in Napp Pharmaceuticals’ provision/funding of pharmacist-led asthma/diabetes reviews (linked by the complainant to QOF activity).The complainant said th…
Clauses: NONE
🔒 Subscribers only
AUTH/2988/10/17
Social Media & Digital Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Employee v Otsuka (AUTH/2988/10/17)
An anonymous complainant (an Otsuka UK employee) raised concerns about a named medical science liaison (MSL) employee’s use of a personal LinkedIn account.The employee had 300+ LinkedIn followers…
Clauses: NONE
🔒 Subscribers only
AUTH/2982/10/17
HCP Hospitality & Meetings Not Upheld 🏥 Immunology & Rheumatology ▶ Video 🎙 Podcast
Anonymous member of the public v Leo (Kyntheum)
An anonymous, non-contactable complainant (describing themselves as a member of the public) said they attended a job interview at Leo for a role involving Kyntheum (brodalumab).They alleged there w…
Clauses: NONE
🔒 Subscribers only
AUTH/2978/9/17
HCP Hospitality & Meetings Upheld 🏥 Immunology & Rheumatology ▶ Video 🎙 Podcast
Janssen pre-licence promotion finding over IL-23 symposium (Tremfya/guselkumab) at BAD 2017 (AUTH/29
An anonymous, non-contactable consultant dermatologist complained about a Janssen symposium at the British Association of Dermatologists (BAD) annual meeting (Liverpool, July 2017) titled “Emergi…
Clauses: 9.1,15.2
🔒 Subscribers only
AUTH/2970/8/17
Data & Publications Not Upheld 🏥 Diabetes ▶ Video 🎙 Podcast
Janssen promotional email about Invokana rebates
An anonymous, non-contactable complainant raised concerns about a Janssen regional business manager (RBM) and an email promoting/relating to Invokana (canagliflozin) for type 2 diabetes.The complai…
Clauses: NONE
🔒 Subscribers only
AUTH/2969/8/17
HCP Hospitality & Meetings Not Upheld 🏥 Diabetes ▶ Video 🎙 Podcast
AstraZeneca
A senior practice nurse complained about the conduct of an AstraZeneca UK medical representative promoting Forxiga (dapagliflozin) for type 2 diabetes.The nurse alleged repeated unbooked “self-pr…
Clauses: NONE
🔒 Subscribers only
AUTH/2961/6/17
Social Media & Digital Not Upheld 🏥 Infectious Diseases ▶ Video 🎙 Podcast
Martindale
Indivior complained about Martindale’s promotion of Espranor (buprenorphine oral lyophilisate) versus Indivior’s Subutex (buprenorphine sublingual tablets). Materials at issue: two detail aids …
Clauses: NONE
🔒 Subscribers only
AUTH/2997/12/17
HCP Hospitality & Meetings Not Upheld 🏥 Infectious Diseases ▶ Video 🎙 Podcast
AbbVie breached certification rules for an uncoded ‘Pathways’ workshop document at a Synagis promoti
An anonymous, contactable health professional complained about how an AbbVie representative presented Synagis (palivizumab) clinical data at a hospital meeting (15 Sept 2017) titled “Mini Embrace…
Clauses: NONE
🔒 Subscribers only
AUTH/2987/10/17
HCP Hospitality & Meetings Not Upheld 🏥 Other ▶ Video 🎙 Podcast
Shire
An anonymous, contactable complainant (appearing to be an ex-employee) raised concerns about Shire’s communications with payers/KOLs and other stakeholders.Three areas were investigated: (1) a ma…
Clauses: NONE
🔒 Subscribers only
AUTH/2957/5/17
Off-label Promotion Upheld 🏥 Musculoskeletal & Bone ▶ Video 🎙 Podcast
Astellas UK
Astellas UK voluntarily admitted that promotional materials referring to both Betmiga (mirabegron) and solifenacin (Vesicare) included prescribing information (PI) for Betmiga only.It also admitted…
Clauses: 4.3,4.4
🔒 Subscribers only
AUTH/2962/7/17
Social Media & Digital Not Upheld 🏥 Other ▶ Video 🎙 Podcast
Pierre Fabre publicly reprimanded after uncertified sales meeting slides and incomplete submission t
An anonymous sales representative complained on behalf of a group of reps promoting Toviaz (fesoterodine) about call rates and certification/approval of meetings and materials. Allegations included…
Clauses: NONE
🔒 Subscribers only
AUTH/2958/5/17
Social Media & Digital Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Astellas Europe
Astellas Pharma Europe voluntarily admitted an electronic advertisement for Xtandi (enzalutamide) referred to the medicine as “new” more than 12 months after introduction/availability of the re…
Clauses: 3.2
🔒 Subscribers only
AUTH/2984/10/17
Data & Publications Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Astellas UK
A hospital doctor alleged Astellas UK inappropriately awarded research funding (~£250,000) in 2009 in association with use of Advagraf (tacrolimus) in a renal transplant protocol (Advagraf de novo…
Clauses: NONE
🔒 Subscribers only
AUTH/2981/9/17
HCP Hospitality & Meetings Not Upheld 🏥 Infectious Diseases ▶ Video 🎙 Podcast
ViiV Healthcare
A member of the public complained that a person using an iPad on a train had Triumeq (dolutegravir/abacavir/lamivudine) sales strategy and clinical information clearly visible. The complainant wa…
Clauses: NONE
🔒 Subscribers only
AUTH/3001/12/17
Data & Publications Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Sunovion
A matter was raised by the PMCPA Director concerning clinical trial disclosure relating to Latuda.The complaint was received on 20 December 2017 under the 2016 ABPI Code.
Clauses: NONE
🔒 Subscribers only
AUTH/3007/12/17
Data & Publications Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Vifor Fresenius
The PMCPA Director reviewed a matter relating to clinical trial disclosure for Velphoro involving Vifor Fresenius.The review was assessed under the ABPI Code of Practice (Applicable Code year: 2016…
Clauses: NONE
🔒 Subscribers only
AUTH/3006/12/17
Data & Publications Not Upheld 🏥 Diabetes ▶ Video 🎙 Podcast
PMCPA AUTH/3006/12/17
A complaint was brought by the PMCPA Director against Lilly.The subject matter related to clinical trial disclosure for Trulicity.Complaint received: 20 December 2017.Case completed: 06 March 2018.
Clauses: NONE
🔒 Subscribers only
AUTH/3004/12/17
Data & Publications Not Upheld 🏥 Infectious Diseases ▶ Video 🎙 Podcast
Gilead
The PMCPA Director raised a case concerning clinical trial disclosure relating to Sovaldi.The case was considered under the ABPI Code of Practice (Applicable Code year: 2016).
Clauses: NONE
🔒 Subscribers only
AUTH/3003/12/17
Data & Publications Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Clinuvel UK
A complaint was brought by the PMCPA Director against Clinuvel UK.The subject matter related to clinical trial disclosure for Scenesse.Complaint received: 20 December 2017.
Clauses: NONE
🔒 Subscribers only
AUTH/3002/12/17
Data & Publications Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Octapharma
The PMCPA Director raised a case against Octapharma concerning clinical trial disclosure relating to Nuwiq.The case was considered under the ABPI Code of Practice (Applicable Code year: 2016).
Clauses: NONE
← Prev 30 31 32 33 34 35 36 Next → Page 33 of 73 — 1752 cases
Unlock the Full Case Library
Annual subscription — instant access, cancel anytime.
🏆
The only PMCPA case library of its kind
No other provider publishes a structured, searchable library of PMCPA rulings with video and podcast. A single half-day compliance workshop from a specialist provider typically costs £499+ — for one session. Individual access here is £299 for a full year of 2,000+ cases.
PMCPA Case Library — Team (100 seats)
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
Enquire for bulk pricing →
Individual
For a single learner
£299
per year
Less than a single half-day workshop
  • 1 user seat
  • All 1752+ case studies
  • Video + podcast per case
  • MCQ quiz per case
  • 5 points per case passed
  • New cases added monthly
Create account or sign in to buy
Team 25+
25+ team members
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
  • 25 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • Bulk seat management
  • Priority support
Enquire for bulk pricing →

Questions? Email [email protected]  ·  14-day money-back guarantee  ·  Annual subscription, auto-renews